PTC THERAPEUTICS H-1B Visa Sponsorship & Salary Data

The median H-1B salary at PTC THERAPEUTICS is $111,000, based on 80 certified filings from FY 2020 to FY 2026. This is 8% lower than the national H-1B median salary of $120,000. Compensation at PTC THERAPEUTICS reflects their market positioning, with entry-level roles starting around $95,200 and senior positions reaching $155,200 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at PTC THERAPEUTICS range from $76,390 at the 10th percentile to $155,200 at the 90th percentile, showing a $78,810 spread across experience levels and roles. The 25th percentile is $95,200 and the 75th percentile is $132,737.

Yes, PTC THERAPEUTICS actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 80 H-1B labor condition applications from FY 2020 to FY 2026, demonstrating ongoing commitment to hiring international talent. With 80 certified applications and a 0% denial rate, PTC THERAPEUTICS maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), PTC THERAPEUTICS filed 1 H-1B applications, with 1 certified and 0 denied. Over 7 years of data, PTC THERAPEUTICS has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

PTC THERAPEUTICS's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 80 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating PTC THERAPEUTICS as a potential H-1B sponsor.

This is an excellent approval rate, indicating PTC THERAPEUTICS has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

PTC THERAPEUTICS sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 80 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles PTC THERAPEUTICS most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at PTC THERAPEUTICS:

The most frequently sponsored role is Research Scientist with 18 filings at a median salary of $104,900. This is followed by Associate Research Scientist (10 filings) and Senior Research Scientist.

PTC THERAPEUTICS's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where PTC THERAPEUTICS sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top PTC THERAPEUTICS H-1B locations:

The largest H-1B hub for PTC THERAPEUTICS is South Plainfield, NJ with 24 filings at a median salary of $102,300. The highest-paying location is Lynnfield, MA at $159,146 median. Salaries range from $97,300 to $159,146 across office locations.

PTC THERAPEUTICS's median H-1B salary has increased by +15% from FY 2020 ($135,000) to FY 2026 ($155,200). Tracking salary trends over time reveals how PTC THERAPEUTICS adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at PTC THERAPEUTICS.

Year-by-year breakdown:

• FY 2022: $102,300 (30 certified)
• FY 2023: $95,300 (13 certified)
• FY 2024: $124,900 (9 certified)
• FY 2025: $123,600 (7 certified)
• FY 2026: $155,200 (1 certified)

PTC THERAPEUTICS has maintained steady salary growth for H-1B positions over this period.

PTC THERAPEUTICS primarily files H-1B applications at Wage Level II, accounting for 36% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making PTC THERAPEUTICS's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

PTC THERAPEUTICS has a mix of entry-level (Level I) and experienced (Level II+) H-1B positions. This reflects a range of roles from junior to senior.

PTC THERAPEUTICS's median H-1B salary of $111,000 is 8% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating PTC THERAPEUTICS's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare PTC THERAPEUTICS's offerings with similar companies in your field for a more accurate assessment.

PTC THERAPEUTICS's H-1B salaries are competitive with industry averages. The 80 total filings indicate active H-1B sponsorship.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. PTC THERAPEUTICS files 24% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 80 certified filings, PTC THERAPEUTICS invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.